New York State Common Retirement Fund’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.1K Hold
10,300
– – ﹤0.01% 3065
2026
Q1
$43K Hold
10,300
– – ﹤0.01% 2861
2025
Q4
$28.3K Hold
10,300
– – ﹤0.01% 3035
2025
Q3
$35.3K Hold
10,300
– – ﹤0.01% 3024
2025
Q2
$35.4K Hold
10,300
– – ﹤0.01% 3029
2025
Q1
$21.9K Hold
10,300
– – ﹤0.01% 2960
2024
Q4
$32.9K Hold
10,300
– – ﹤0.01% 2957
2024
Q3
$138K Sell
10,300
-8,700
-46% -$116K ﹤0.01% 2453
2024
Q2
$189K Buy
+19,000
New +$275K ﹤0.01% 2448

Other funds holding CATX

New York State Common Retirement Fund's CATX Position: Q2 2026 in Review

New York State Common Retirement Fund held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 10,300 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3065.

New York State Common Retirement Fund first reported a position in CATX in Q2 2024 and has held it in 9 quarters since. The position peaked at $189K in Q2 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • New York State Common Retirement Fund held 10,300 shares of Perspective Therapeutics worth $35.1K as of Q2 2026.
  • New York State Common Retirement Fund left its Perspective Therapeutics share count unchanged in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3065 holding.
  • New York State Common Retirement Fund first reported a position in Perspective Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • New York State Common Retirement Fund's Perspective Therapeutics position peaked at $189K in Q2 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.